The future in diagnosis and staging of lung cancer. Molecular techniques.

about

The future in diagnosis and staging of lung cancer. Molecular techniques.

Item

http://www.wikidata.org/entity/Q36606755

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

The future in diagnosis and staging of lung cancer. Molecular techniques.

@ast

The future in diagnosis and staging of lung cancer. Molecular techniques.

@en

type

Item

label

The future in diagnosis and staging of lung cancer. Molecular techniques.

@ast

The future in diagnosis and staging of lung cancer. Molecular techniques.

@en

prefLabel

The future in diagnosis and staging of lung cancer. Molecular techniques.

@ast

The future in diagnosis and staging of lung cancer. Molecular techniques.

@en

P1476

The future in diagnosis and staging of lung cancer. Molecular techniques.

@en

P2093

Andreas Kirschbaum

http://www.w3.org/2001/XMLSchema#string

Bernward Passlick

http://www.w3.org/2001/XMLSchema#string

Peter Ehrhardt

http://www.w3.org/2001/XMLSchema#string

Sebastian Dango

http://www.w3.org/2001/XMLSchema#string

Stephan Eggeling

http://www.w3.org/2001/XMLSchema#string

Wulf Sienel

http://www.w3.org/2001/XMLSchema#string

P2860

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Mutations in the p53 gene occur in diverse human tumour types

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

Detection and clinical importance of micrometastatic disease.

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.

Molecular predictors of response to chemotherapy in lung cancer.

Early detection of lung cancer.

Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients.

Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients.

P304

575-580

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000095310

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17008784

http://www.w3.org/2001/XMLSchema#string